Cargando…
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
BACKGROUND: Immune escape of tumor cells is a new hallmark of cancer in general, and breast cancer, in particular. Previous studies have demonstrated that the immunological profile in peripheral blood may be a prognostic and/or predictive biomarker in breast cancer. Thus, higher number of regulatory...
Autores principales: | Sánchez-Margalet, Víctor, Barco-Sánchez, Antonio, Vilariño-García, Teresa, Jiménez-Cortegana, Carlos, Pérez-Pérez, Antonio, Henao-Carrasco, Fernando, Virizuela-Echaburu, Juan A., Nogales-Fernández, Esteban, Álamo-de la Gala, María C., Lobo-Acosta, María A., Palazón-Carrión, Natalia, Nieto, Adoración, de la Cruz-Merino, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798280/ https://www.ncbi.nlm.nih.gov/pubmed/35116734 http://dx.doi.org/10.21037/tcr.2018.12.30 |
Ejemplares similares
-
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón‑Carrión, Natalia, et al.
Publicado: (2021) -
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón-Carrión, Natalia, et al.
Publicado: (2021) -
Leptin, Both Bad and Good Actor in Cancer
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
Obesity and Risk for Lymphoma: Possible Role of Leptin
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2022)